Artelo Biosciences Stock Market Outlook
| ARTL Stock | USD 1.20 0.09 6.98% |
About 78 percent of Artelo Biosciences' institutional investors are selling. The analysis of overall sentiment of trading Artelo Biosciences stock suggests that many investors are terrified at this time. Artelo Biosciences' investing sentiment shows overall attitude of investors towards Artelo Biosciences.
Comfort Level 22
Terrified
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Artelo Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Artelo Biosciences.
News SentimentBearish | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Artelo Biosciences is 'Strong Hold'. The recommendation algorithm takes into account all of Artelo Biosciences' available fundamental, technical, and predictive indicators you will find on this site.
Execute Artelo Biosciences Advice
The Artelo recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Artelo Biosciences. Macroaxis does not own or have any residual interests in Artelo Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Artelo Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Weakest | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Strong | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Artelo Biosciences has a Risk Adjusted Performance of (0.07), Jensen Alpha of (0.65), Total Risk Alpha of (1.14) and Treynor Ratio of 3.51We provide trade advice to complement the prevailing expert consensus on Artelo Biosciences. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Artelo Biosciences is not overpriced, please confirm all Artelo Biosciences fundamentals, including its beta, current asset, as well as the relationship between the cash flow from operations and cash per share . Given that Artelo Biosciences is a hitting penny stock territory we recommend to closely look at its price to earning.
Artelo Biosciences Trading Alerts and Improvement Suggestions
| Artelo Biosciences generated a negative expected return over the last 90 days | |
| Artelo Biosciences has high historical volatility and very poor performance | |
| Artelo Biosciences may become a speculative penny stock | |
| Artelo Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences currently holds about 21.32 M in cash with (8.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Artelo Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Stock Analysis Is Artelo Biosciences Inc impacted by rising rates - Weekly Trade Review Accurate Intraday Trading Signals - baoquankhu1.vn |
Artelo Biosciences current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Artelo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Artelo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Artelo Biosciences Returns Distribution Density
The distribution of Artelo Biosciences' historical returns is an attempt to chart the uncertainty of Artelo Biosciences' future price movements. The chart of the probability distribution of Artelo Biosciences daily returns describes the distribution of returns around its average expected value. We use Artelo Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Artelo Biosciences returns is essential to provide solid investment analysis for Artelo Biosciences.
| Mean Return | -0.65 | Value At Risk | -8.33 | Potential Upside | 7.30 | Standard Deviation | 6.41 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Artelo Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Artelo Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2025-06-30 | 16 K | Tower Research Capital Llc | 2025-06-30 | 447 | Ubs Group Ag | 2025-06-30 | 89.0 | Citigroup Inc | 2025-06-30 | 9.0 | Bank Of America Corp | 2025-06-30 | 5.0 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 4.0 | Fmr Inc | 2025-06-30 | 1.0 | Susquehanna International Group, Llp | 2025-06-30 | 0.0 | Rothschild Investment, Llc | 2025-06-30 | 0.0 | Citadel Advisors Llc | 2025-06-30 | 0.0 |
Artelo Biosciences Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 4.5M | (5.3M) | (4.1M) | (477K) | (429.3K) | (450.8K) | |
| Free Cash Flow | (6.1M) | (8.0M) | (8.2M) | (8.4M) | (7.5M) | (7.1M) | |
| Other Non Cash Items | 7K | (211K) | (641K) | (279K) | (251.1K) | (238.5K) | |
| Net Income | (7.4M) | (10.1M) | (9.3M) | (9.8M) | (8.8M) | (8.4M) | |
| End Period Cash Flow | 6.6M | 6.9M | 2.8M | 2.3M | 2.7M | 2.6M |
Artelo Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Artelo Biosciences or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Artelo Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Artelo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.65 | |
β | Beta against Dow Jones | -0.19 | |
σ | Overall volatility | 6.48 | |
Ir | Information ratio | -0.11 |
Artelo Biosciences Volatility Alert
Artelo Biosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Artelo Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Artelo Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Artelo Biosciences Fundamentals Vs Peers
Comparing Artelo Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Artelo Biosciences' direct or indirect competition across all of the common fundamentals between Artelo Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Artelo Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Artelo Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Artelo Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Artelo Biosciences to competition |
| Fundamentals | Artelo Biosciences | Peer Average |
| Return On Equity | -4.36 | -0.31 |
| Return On Asset | -1.36 | -0.14 |
| Current Valuation | 2.01 M | 16.62 B |
| Shares Outstanding | 2.02 M | 571.82 M |
| Shares Owned By Insiders | 0.47 % | 10.09 % |
| Shares Owned By Institutions | 1.63 % | 39.21 % |
| Number Of Shares Shorted | 110.41 K | 4.71 M |
| Price To Earning | 16.31 X | 28.72 X |
| Price To Book | 0.50 X | 9.51 X |
| EBITDA | (10.11 M) | 3.9 B |
| Net Income | (9.83 M) | 570.98 M |
| Cash And Equivalents | 21.32 M | 2.7 B |
| Cash Per Share | 7.51 X | 5.01 X |
| Total Debt | 104 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 42.28 X | 2.16 X |
| Book Value Per Share | (0.41) X | 1.93 K |
| Cash Flow From Operations | (8.35 M) | 971.22 M |
| Short Ratio | 0.45 X | 4.00 X |
| Earnings Per Share | (19.50) X | 3.12 X |
| Target Price | 18.0 | |
| Number Of Employees | 6 | 18.84 K |
| Beta | 1.02 | -0.15 |
| Market Capitalization | 3.51 M | 19.03 B |
| Total Asset | 4.7 M | 29.47 B |
| Retained Earnings | (50.14 M) | 9.33 B |
| Working Capital | 785 K | 1.48 B |
| Current Asset | 99.89 M | 9.34 B |
| Current Liabilities | 23.67 M | 7.9 B |
| Net Asset | 4.7 M |
Note: Acquisition by Gorgas Gregory D. of 154713 shares of Artelo Biosciences at 1.68 subject to Rule 16b-3 [view details]
Artelo Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Artelo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Artelo Biosciences Buy or Sell Advice
When is the right time to buy or sell Artelo Biosciences? Buying financial instruments such as Artelo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Artelo Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agriculture ETFs Thematic Idea Now
Agriculture ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Agriculture ETFs theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Artelo Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.